Alphatec Holdings, Inc. (ATEC)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$9.45+1.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ATEC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 815.1 | 764.2 | 611.6 | 482.3 | 350.9 | 243.2 | 144.9 | 113.4 | 91.7 | 101.7 | 120.2 | 134.4 | 154.6 | 204.7 | 196.3 | 197.7 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 101.7 | 120.2 | 134.4 | 154.6 | 204.7 | 196.3 | 197.7 |
| Cost of Revenues | 237.7 | 232.3 | 187.3 | 172.1 | 117.8 | 85.5 | 42.4 | 35.8 | 28.5 | 33.5 | 44.1 | 46.4 | 45.0 | 78.7 | 70.8 | 79.2 |
| Gross Profit | 577.4 | 531.9 | 424.3 | 310.2 | 233.1 | 157.8 | 102.5 | 77.6 | 63.2 | 68.2 | 76.1 | 88.0 | 109.7 | 124.3 | 123.8 | 116.9 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 524.1 | 498.5 | 450.2 | 374.1 | 300.0 | 229.3 | 129.2 | 101.7 | 72.6 | — | — | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — | — | — | — | — | — | — | 17.8 | 16.8 | 14.2 | 14.9 | 16.9 |
| Operating Income | (49.2) | (82.1) | (136.2) | (173.4) | (147.0) | (128.1) | (58.9) | (47.3) | (22.4) | (9.0) | (15.4) | (175.9) | 1.5 | (73.4) | (9.8) | (24.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 48.5 | 45.9 | 24.9 | 16.6 | 5.5 | 7.1 | 12.4 | — | — | — | 5.4 | 4.0 | 3.0 | 4.0 | 6.1 | 3.0 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | 5.4 | 4.0 | 3.0 | 4.0 | 6.0 | 2.9 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | (9.9) | (7.7) | 4.4 | (15.6) | 3.5 | (1.2) | (5.6) | (6.8) | (2.2) |
| EBT, Incl. Unusual Items | (109.7) | (143.4) | (162.1) | (186.9) | (152.0) | (144.2) | (78.8) | (57.2) | (30.3) | (4.6) | (30.9) | (172.4) | 0.3 | (79.0) | (16.6) | (26.7) |
| Income Tax Expense | 0.3 | (0.0) | 0.1 | (0.3) | (0.7) | (1.1) | 0.1 | (0.2) | (1.4) | (0.0) | (4.6) | (1.1) | 0.4 | 3.2 | (1.2) | (4.5) |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (15.5) | (22.2) |
| Net Income | ||||||||||||||||
| Net Income | (110.0) | (143.4) | (162.1) | (186.6) | (151.3) | (143.0) | (79.0) | (57.0) | (29.0) | (2.3) | (29.9) | (178.7) | (12.9) | (82.2) | (15.5) | (22.2) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.70) | (0.96) | (1.13) | (1.54) | (1.46) | (1.49) | (1.18) | — | (1.20) | (0.18) | (3.49) | (21.53) | (1.59) | — | — | — |
| Diluted EPS | (0.70) | (0.96) | (1.13) | (1.54) | (1.46) | (1.49) | (1.18) | — | (1.20) | (1.08) | (3.49) | (21.53) | (1.90) | — | — | — |
| Revenue per Share | 5.21 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 156.6 | 150.1 | 142.9 | 121.2 | 103.4 | 96.2 | 67.0 | — | 35.3 | 12.8 | 8.6 | 8.3 | 8.1 | 96.2 | 90.2 | — |
| Diluted Weighted Avg Shares | 156.6 | 150.1 | 142.9 | 121.2 | 103.4 | 96.2 | 67.0 | — | 35.3 | 13.3 | 8.6 | 8.3 | 8.1 | 96.2 | 90.2 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (4.6) | (57.8) | (117.3) | (105.8) | (101.3) | (47.9) | (39.7) | (15.7) | (1.5) | (3.0) | (156.8) | 19.9 | (47.2) | 14.0 | (4.6) |
| EBIT | (49.2) | (82.1) | (136.2) | (173.4) | (147.0) | (128.1) | (58.9) | (47.3) | (22.4) | (9.0) | (15.4) | (175.9) | 1.5 | (73.4) | (9.8) | (24.5) |
| Effective Tax Rate | -0.2% | — | — | 0.1% | 0.5% | 0.8% | -0.2% | 0.4% | 4.5% | 0.7% | 15.0% | 0.7% | 131.7% | -4.0% | 7.0% | 16.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.